Press Releases for KNSY

Press Releases
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2009 Financial Results
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference
ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark
Kensey Nash Corporation's CEO & President, Joe Kaufmann Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in Greater Philadelphia Region
Kensey Nash Corporation Adopts Stockholder Rights Plan
Kensey Nash to Present at the Jefferies 3rd Annual Healthcare Conference
Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
Spectranetics Reports 15% Revenue Growth in First Quarter 2009
Kensey Nash to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
Kensey Nash Announces 600,000 Share Stock Repurchase Program
Kensey Nash Announces Director Resignation - Mar 13 2009 11:30AM
Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
Kensey Nash Announces Appointment of Chief Financial Officer
Kensey Nash Announces IDE Submission for Cartilage Repair Device
Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
Kensey Nash Announces Director Resignation - Feb 4 2009 1:51PM
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
Kensey Nash to Participate in the Sidoti Sixth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
Globus Medical Strengthens Executive Team with Appointment of CFO
Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
Kensey Nash Corporation Announces Resignation of Chief Financial Officer
Kensey Nash Reports First Quarter Fiscal Year 2009 Results
Kensey Nash to Present at the Sidoti & Company New York Emerging Growth Institutional Investor Conference II
Kensey Nash Accomplishes First Milestone Under Spectranetics Agreements
Kensey Nash Corporation Announces Its First Quarter 2009 Earnings Release Date and Teleconference
Kensey Nash to Present at the 2008 UBS Global Life Sciences Conference
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference
Kensey Nash Provides 4th Quarter Fiscal 2008 and Fiscal Year 2009 Guidance
Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
Kensey Nash to Participate in the Friedman Billings Ramsey 12th Annual Spring Investor Conference - May 26 2008 10:32PM
Spectranetics Acquires Endovascular Business of Kensey Nash - May 27 2008 12:41AM
Kensey Nash Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics - May 27 2008 12:41AM
Corrected Press Release: Kensey Nash to Present at the Bank of America 2008 Health Care Conference - Jun 1 2008 11:57PM
Kensey Nash to Present at the Bank of America 2008 Health Care Conference - Jun 1 2008 11:56PM
Kensey Nash Reports Third Quarter Record Revenue and Sales
Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
Kensey Nash Reports Third Quarter Fiscal Year 2006 Results at High End of Previously Announced Estimates
Kensey Nash Reports First Quarter Fiscal Year 2006 Results
Kensey Nash Reports Fourth Quarter and Fiscal Year 2005 Results - Fourth Quarter Pro-Forma EPS of $0.32 and as Reported EPS of $0.27 - - Fiscal Year 2005 Pro-Forma EPS of $1.11 and as Reported EPS of $1.06 -